Share

Development and validation of an analytical method in mass spectrometry for the measurement of plasma levels of tamoxifen and endoxifen in cancer patients. Ingengineering and marketing of ready-to-use analytical KIT dedicated to routine care.

Scientific collaboration with EUREKA - Lab Division srl

Project objectives

Monitoring of plasma concentrations of tamoxifen and endoxifen in cancer patients.

Start and end date

2016 - 2017

Project Manager

Prof. Pierantonio Menna, UR Clinical Pharmacology, Department of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma; Campus Bio-Medico University Polyclinic Foundation - Principal Investigator
Prof. Girogio Minotti, Head of Pharmaceutical Sciences UR, Università Campus Bio-Medico di Roma and Fondazione Policlinico Universitario Campus Bio-Medico, Rome - Co-Principal Investigator
prof Emanuela Salvatorelli, UR Pharmaceutical Sciences, Campus Bio-Medico University, Rome - Co-Principal Investigator

Coordinating institution of the project

UR Pharmaceutical Sciences, Departmental Faculty of Medicine and Surgery, Integrated Research Center, Campus Bio-Medico University, Rome
magnifiercrossmenuchevron-downchevron-leftchevron-right